Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Bio-Path Stock Performance Shares of Bio-Path stock opened at $0.77 on Friday. Bio-Path has a twelve month low of $0.61 and a twelve month high of $12.37. The business […]
More Stories
Ukraine Reports Crash of One of Its F-16s, Pilot Safe
By Victoria Friedman The Armed Forces of Ukraine said one of its F-16 fighter jets had crashed, and that the...
US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions US Gas Prices Remain Elevated Amid Ongoing Middle East Tensions
By Naveen Athrappully Gasoline prices in the United States continue to remain high at over $4 per gallon as the...
Spain’s Ceuta Overwhelmed as Nearly 60,000 Illegal Immigrants Cross From Morocco in a Day
By Owen Evans Ceuta was overwhelmed overnight as the Spanish North African exclave faced a fresh wave of nearly 60,000...
Spain’s Mass Illegal Immigration Crisis: What to Know
By Troy Myers Tens of thousands of illegal immigrants crossed from Morocco into Spain in a single day, igniting worldwide...
Weekly Unemployment Claims Remain at Historically Low Levels
By Andrew Moran The number of Americans applying for unemployment benefits remained at historically low levels last week, as layoffs...
US Government Acquires Equity Stakes in 7 More Companies
By Andrew Moran The Department of Commerce said on July 29 it will allocate $874 million in incentives to bolster...